When to Extend Monitoring of Anti-drug Antibodies for High-risk Biotherapeutics in Clinical Trials: an Opinion from the European Immunogenicity Platform.
- Resource Type
- Academic Journal
- Source
- AAPS Journal; May2022, Vol. 24 Issue 3, p1-7, 7p
- Subject
- Language
- ISSN
- 15507416